| 
收听数0听众数8最后登录2025-1-7QQUID9301阅读权限10帖子1191精华0在线时间380 小时注册时间2014-5-1
 
 
 科研币2 速递币25 娱乐币1820 文献值0 资源值0 贡献值0 
 | 
5速递币 
| | 题名 | Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial. |  | 链接 | http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(14)60845-X.pdf | 
 | 
 |